-

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Officers and Directors of NewAge, Inc. (NBEVQ)

SAN DIEGO--(BUSINESS WIRE)--The Class: Robbins LLP informs investors that a shareholder filed a class action on behalf of all investors who purchased NewAge, Inc. (OTC: NBEVQ) securities between January 18, 2018 and October 18, 2022, for violations of the Securities Exchange Act of 1934. NewAge purports to produce and sell various beverages and other health products.

What Now: Similarly situated shareholders may be eligible to participate in the class action against the officers and directors of NewAge. Shareholders who want to act as lead plaintiff for the class must file their papers by February 6, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

What is this Case About: The Officers and Directors of NewAge, Inc. (NBEVQ) Caused the Company to Issue False and Misleading Statements Regarding its Business Prospects

According to the complaint, during the class period, defendants made a series of false and misleading statements concerning distribution agreements and partnerships with the U.S. military, expanded distribution of products to "all major retailers throughout Canada…", and agreements "with the largest food and beverage distributor in South Korea to expand to all major retail outlets throughout the country immediately." Defendants also made misleading statements regarding testing and developing CBD-infused beverages. Finally, defendants made misleading statements regarding its distribution agreement with Walmart.

In December 2020, NewAge completed its acquisition of Ariix. Thereafter, it developed concerns that Ariix had violated the Foreign Corrupt Practices Act (“FCPA”). In August 2021, NewAge made a voluntary self-disclosure of suspected FCPA issues to the U.S. Department of Justice and the SEC. The Company further disclosed that as of June 30, 2021, a material weakness existed relating to the Company's “failure to design and implement monitoring activities over the acquisition of Ariix that resulted in the ability to issue our consolidated financial statements [. . .].”

On January 10, 2022, NewAge announced defendant Brent Willis would resign as CEO, Director, and employee of the Company. NewAge announced it was filing for Chapter 11 bankruptcy relief on August 30, 2022. As a result, the Company's stock stopped trading on September 8, 2022.

On October 18, 2022, the SEC announced it was taking legal action against defendant Willis as he engaged in a “multi-year fraud by disseminating numerous false and misleading press releases and making false public statements concerning NewAge’s business dealings, and aided and abetted NewAge’s disclosure of material information in violation of Regulation FD.”

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against NewAge, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

OTC Pink:NBEVQ

Release Summary
The Officers and Directors of NewAge, In. (NBEVQ) Caused the Company to Issue False and Misleading Statements Regarding its Business Prospects
Release Versions
$Cashtags

Contacts

Aaron Dumas
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the Vistagen Therapeutics, Inc. Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a class action was filed on behalf of all investors who purchased or otherwise acquired Vistagen Therapeutics, Inc. (NASDAQ: VTGN) common stock between April 1, 2024 and December 16, 2025. Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders. For more information, submit a form, email attorney Aaron Dumas...

Investor Notice: Robbins LLP Informs Investors of the Securities Class Action Against Oracle Corporation

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a class action was filed on behalf of all persons and/or entities who purchased or otherwise acquired Oracle Corporation (NYSE: ORCL) Senior Notes issued pursuant to the Shelf Registration Statement filed with the SEC on March 15, 2024, and as supplemented on September 25, 2025. Oracle is an Austin, Texas-based company that sells database software, enterprise applications, and cloud infrastructure and hardware. For more information,...

Investor Notice: Robbins LLP Informs Investors of the Smart Digital Group Limited Securities Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Smart Digital Group Limited (NASDAQ: SDM) securities between May 5, 2025 and September 26, 2025. Smart Digital, together with its subsidiaries, provides internet media, business planning and consulting, event planning and execution, and software customization and marketing services in Mainland China and Macau. For more information, submit a fo...
Back to Newsroom